 |
|
| ADVANCES IN DRUG RESEARCH, 26
| |
| | |
|
|
To order this title, and for more information, click here
Bernard Testa, University Hospital Centre, Lausanne, Switzerland
Urs Meyer, Biocentre, University of Basel, Switzerland
Description
Volume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining
the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded
to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology.
Audience
Pharmacologists, medicinal chemists, and toxicologists.
Contents
L.B. Kier and B. Testa, Complexity and Emergence in Drug Research.M.S. Tute, Drug Design: the Present and the Future.
K. Burki and B. Ledermann, Transgenic Animals as Pharmacological Tools.C.L. Crespi, Xenobiotic-metabolizing Human
Cells as Tools for Pharmacological and Toxicological Research.J. Urquhart, Correlates of Variable Patient Compliance in Drug
Trials: Relevance in the New Health Care Environment.
Subject Index.
Cumulative Index of Authors.
Cumulative Index of Titles.
| Bibliographic details |
Hardbound, 279 pages, publication date: SEP-1995
ISBN-13: 978-0-12-013326-0
ISBN-10: 0-12-013326-1
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
USD 150
EUR 106.95
GBP 90.99
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
999/999
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company